Compounds > lutetium
Page last updated: 2024-08-22

lutetium and Breast Neoplasms

lutetium has been researched along with Breast Neoplasms in 19 studies

Research

Studies (19)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (5.26)18.2507
2000's3 (15.79)29.6817
2010's12 (63.16)24.3611
2020's3 (15.79)2.80

Authors

AuthorsStudies
Asensio, AF; Bettmer, J; Blanco-González, E; Corte-Rodríguez, M; Montes-Bayón, M; Sierra, LM1
Chuvilin, DY; Deev, SM; Egorova, BV; Golovachenko, VA; Kaprin, AD; Kokov, KV; Lebedenko, EN; Nemtsova, ER; Pankratov, AA; Plyutinskaya, AD; Proshkina, GM; Shegai, PV; Shul'ga, AA; Vorontsova, MS1
Das, T; Mukherjee, A; Sarma, HD; Satpati, D; Sharma, AK; Sharma, R; Vats, K1
Dash, A; Gamre, N; Kameswaran, M; Pandey, U; Sarma, HD1
Al-Ejeh, F; Brown, MP; Chenevix-Trench, G; Khanna, KK; Lakhani, SR; Miranda, M; Shi, W; Simpson, PT; Song, S; Swarbrick, A; Vargas, AC; Welm, AL; Wiegmans, AP1
Cai, Z; Lu, Y; Pignol, JP; Reilly, RM; Winnik, MA; Yook, S2
Cai, Z; Chan, C; Chen, JC; Razumienko, EJ; Reilly, RM1
Aranda-Lara, L; Azorín-Vega, E; Ferro-Flores, G; Isaac-Olivé, K; Jiménez-Mancilla, N; Ocampo-García, B; Ramírez, FM; Santos-Cuevas, C1
Alwarda, R; Cai, Z; Jeong, JJ; Lu, Y; Pignol, JP; Reilly, RM; Tong, L; Winnik, MA; Yook, S1
Bal, A; Bhusari, P; Dhawan, DK; Mittal, BR; Parmar, M; Shukla, J; Singh, G; Vatsa, R1
Babaei, MH; Daha, FJ; Rajabi, H; Rasaneh, S; Salouti, M1
Hossein Babaei, M; Johari Daha, F; Rajabi, H; Rasaneh, S1
Babaei, MH; Daha, FJ; Rajabi, H; Rasaneh, S1
Babaei, MH; Rajabi, H; Rasaee, Mj; Salouti, M1
Backer, JM; Backer, MV; Blankenberg, FG; Goris, MG; Hamby, CV; Levashova, Z1
Banerjee, S; Chakraborty, S; Das, T; Korde, A; Pillai, MR; Samuel, G; Venkatesh, M1
Carrasquillo, JA; Chung, Y; Curt, G; Feuerstein, I; Milenic, DE; Mulligan, T; Paik, C; Perentesis, P; Reynolds, J; Schlom, J1
Cherry, SR; Doshi, NK; Shao, Y; Silverman, RW1

Trials

2 trial(s) available for lutetium and Breast Neoplasms

ArticleYear
Development of Lu-177-trastuzumab for radioimmunotherapy of HER2 expressing breast cancer and its feasibility assessment in breast cancer patients.
    International journal of cancer, 2017, 02-15, Volume: 140, Issue:4

    Topics: Adult; Antineoplastic Agents, Hormonal; Breast Neoplasms; Combined Modality Therapy; Feasibility Studies; Female; Genes, erbB-2; Heterocyclic Compounds, 1-Ring; Humans; Immunoconjugates; Lutetium; Mastectomy; Middle Aged; Molecular Targeted Therapy; Neoplasm Metastasis; Neoplasm Proteins; Pilot Projects; Radioimmunotherapy; Radioisotopes; Receptor, ErbB-2; Single Photon Emission Computed Tomography Computed Tomography; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tamoxifen; Tissue Distribution; Trastuzumab

2017
Phase I study of intravenous Lu-labeled CC49 murine monoclonal antibody in patients with advanced adenocarcinoma.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1995, Volume: 1, Issue:12

    Topics: Adenocarcinoma; Adult; Antibodies, Monoclonal; Antibodies, Neoplasm; Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Female; Humans; Lung Neoplasms; Lutetium; Male; Middle Aged; Neoplasms; Radioimmunotherapy; Radioisotopes; Radiotherapy Dosage

1995

Other Studies

17 other study(ies) available for lutetium and Breast Neoplasms

ArticleYear
Targeting HER2 protein in individual cells using ICP-MS detection and its potential as prognostic and predictive breast cancer biomarker.
    Talanta, 2021, Dec-01, Volume: 235

    Topics: Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Immunoconjugates; Lutetium; Prognosis; Receptor, ErbB-2

2021
Specific Cytotoxicity of Targeted
    Bulletin of experimental biology and medicine, 2021, Volume: 171, Issue:5

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Immunotoxins; Lead Radioisotopes; Lutetium; MCF-7 Cells; Molecular Targeted Therapy; Radioisotopes; Radiopharmaceuticals; Substrate Specificity

2021
Synthesis and comparative evaluation of
    Scientific reports, 2022, Sep-20, Volume: 12, Issue:1

    Topics: Breast Neoplasms; Female; Humans; Lutetium; Peptides; Polyethylene Glycols; Radioisotopes; Radiopharmaceuticals

2022
Preparation of
    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2019, Volume: 148

    Topics: Animals; Antineoplastic Agents, Immunological; Breast Neoplasms; Cell Line, Tumor; Female; Humans; Immunoconjugates; Lutetium; Mice; Radioisotopes; Tissue Distribution; Trastuzumab

2019
Treatment of triple-negative breast cancer using anti-EGFR-directed radioimmunotherapy combined with radiosensitizing chemotherapy and PARP inhibitor.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:6

    Topics: Animals; Antibodies, Monoclonal; Breast Neoplasms; Cell Line, Tumor; Cell Transformation, Neoplastic; Enzyme Inhibitors; ErbB Receptors; Female; Lutetium; Mice; Neoplasm Metastasis; Poly(ADP-ribose) Polymerase Inhibitors; Radiation-Sensitizing Agents; Radioimmunotherapy; Radioisotopes; RNA, Messenger

2013
Radiation Nanomedicine for EGFR-Positive Breast Cancer: Panitumumab-Modified Gold Nanoparticles Complexed to the β-Particle-Emitter, (177)Lu.
    Molecular pharmaceutics, 2015, Nov-02, Volume: 12, Issue:11

    Topics: Antibodies, Monoclonal; Beta Particles; Breast Neoplasms; Cell Nucleus; Cell Survival; ErbB Receptors; Female; Gold; Humans; Lutetium; Metal Nanoparticles; Microscopy, Fluorescence; Nanomedicine; Panitumumab; Radioimmunotherapy; Radiopharmaceuticals; Tumor Cells, Cultured

2015
Dual-Receptor-Targeted Radioimmunotherapy of Human Breast Cancer Xenografts in Athymic Mice Coexpressing HER2 and EGFR Using 177Lu- or 111In-Labeled Bispecific Radioimmunoconjugates.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016, Volume: 57, Issue:3

    Topics: Animals; Breast Neoplasms; ErbB Receptors; Humans; Immunoconjugates; Indium Radioisotopes; Lutetium; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Radioimmunotherapy; Radioisotopes; Radiometry; Radiopharmaceuticals; Receptor, ErbB-2; Tissue Distribution; Xenograft Model Antitumor Assays

2016
Synthesis and evaluation of Lys¹(α,γ-Folate)Lys³(¹⁷⁷Lu-DOTA)-Bombesin(1-14) as a potential theranostic radiopharmaceutical for breast cancer.
    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2016, Volume: 107

    Topics: Animals; Bombesin; Breast Neoplasms; Cell Line, Tumor; Coordination Complexes; Female; Humans; Lutetium; Mice; Mice, Nude; Multimodal Imaging; Oligopeptides; Radioisotopes; Radiopharmaceuticals; Radiotherapy Dosage; Theranostic Nanomedicine; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Xenograft Model Antitumor Assays

2016
Intratumorally Injected 177Lu-Labeled Gold Nanoparticles: Gold Nanoseed Brachytherapy with Application for Neoadjuvant Treatment of Locally Advanced Breast Cancer.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016, Volume: 57, Issue:6

    Topics: Animals; Brachytherapy; Breast Neoplasms; Cell Line, Tumor; Cell Transformation, Neoplastic; Gold; Humans; Injections; Lutetium; Metal Nanoparticles; Mice; Neoadjuvant Therapy; Radioisotopes; Radiometry; Single Photon Emission Computed Tomography Computed Tomography

2016
Stability and Biodistribution of Thiol-Functionalized and (177)Lu-Labeled Metal Chelating Polymers Bound to Gold Nanoparticles.
    Biomacromolecules, 2016, Apr-11, Volume: 17, Issue:4

    Topics: Animals; Beta Particles; Breast Neoplasms; Female; Gold; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Metal Nanoparticles; Mice; Mice, Nude; Nanomedicine; Polymers; Radioisotopes; Radiopharmaceuticals; Sulfhydryl Compounds

2016
Radiolabeling of trastuzumab with 177Lu via DOTA, a new radiopharmaceutical for radioimmunotherapy of breast cancer.
    Nuclear medicine and biology, 2009, Volume: 36, Issue:4

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Breast Neoplasms; Buffers; Cell Line, Tumor; Cell Survival; Drug Stability; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Quality Control; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Staining and Labeling; Trastuzumab

2009
Toxicity of trastuzumab labeled 177Lu on MCF7 and SKBr3 cell lines.
    Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 2010, Volume: 68, Issue:10

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Drug Stability; Female; Humans; Lutetium; Radioisotopes; Radiopharmaceuticals; Receptor, ErbB-2; Trastuzumab

2010
177Lu labeling of Herceptin and preclinical validation as a new radiopharmaceutical for radioimmunotherapy of breast cancer.
    Nuclear medicine and biology, 2010, Volume: 37, Issue:8

    Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Breast Neoplasms; Cell Line, Tumor; Drug Evaluation, Preclinical; Female; Lutetium; Mice; Quality Control; Radioimmunotherapy; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Trastuzumab

2010
Preparation and biological evaluation of (177)Lu conjugated PR81 for radioimmunotherapy of breast cancer.
    Nuclear medicine and biology, 2011, Volume: 38, Issue:6

    Topics: Animals; Antibodies, Monoclonal; Breast Neoplasms; Cell Line, Tumor; Female; Heterocyclic Compounds, 1-Ring; Humans; Lutetium; Mice; Mice, Inbred BALB C; Quality Control; Radioimmunodetection; Radioimmunotherapy; Radioisotopes

2011
Targeted systemic radiotherapy with scVEGF/177Lu leads to sustained disruption of the tumor vasculature and intratumoral apoptosis.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011, Volume: 52, Issue:10

    Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Apoptosis; Bevacizumab; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Combined Modality Therapy; Endothelial Cells; Female; Humans; Indoles; Lutetium; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, SCID; Neovascularization, Pathologic; Pyrroles; Radioisotopes; Radiopharmaceuticals; Receptors, Vascular Endothelial Growth Factor; Sunitinib; Vascular Endothelial Growth Factor A

2011
An estradiol-conjugate for radiolabelling with 177Lu: an attempt to prepare a radiotherapeutic agent.
    Bioorganic & medicinal chemistry, 2005, Jul-01, Volume: 13, Issue:13

    Topics: Breast Neoplasms; Cell Line, Tumor; Chelating Agents; Estradiol; Female; Heterocyclic Compounds, 1-Ring; Humans; Immunoglobulin G; Lutetium; Peptides, Cyclic; Radioimmunoassay; Radiopharmaceuticals

2005
Design and evaluation of an LSO PET detector for breast cancer imaging.
    Medical physics, 2000, Volume: 27, Issue:7

    Topics: Breast Neoplasms; Female; Gamma Cameras; Humans; Lutetium; Mammography; Silicic Acid; Time Factors; Tomography, Emission-Computed; X-Rays

2000